Stock listing
ISPC Stock Price, News, Filings & Events — Ispecimen Inc.
Selected listing: ISPC · NASDAQ · USD · US
This page tracks Ispecimen Inc.'s ISPC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ISPC:NASDAQ. ISPC:NASDAQ is the stock-level entry point for investors researching Ispecimen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ispecimen Inc. is a public company traded on the American market under the ticker ISPC. With a market capitalization of approximately $2.99 million, the company focuses on providing access to human biospecimens for research and development purposes. Ispecimen aims to support advancements in personalized medicine and clinical research through its innovative platform.
- Ticker
- ISPC:NASDAQ
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
Ispecimen Inc. ISPC:NASDAQ stock context
This page tracks Ispecimen Inc.'s ISPC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ISPC:NASDAQ. ISPC:NASDAQ is the stock-level entry point for investors researching Ispecimen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ispecimen Inc. is a public company traded on the American market under the ticker ISPC. With a market capitalization of approximately $2.99 million, the company focuses on providing access to human biospecimens for research and development purposes. Ispecimen aims to support advancements in personalized medicine and clinical research through its innovative platform.
Latest news from Ispecimen Inc.
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
August 7, 2026
ISpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
August 6, 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
May 12, 2026
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 8, 2026
ISpecimen Announces 1-for-40 Reverse Stock Split
April 27, 2026
Ispecimen Inc. earnings calls
iSpecimen Inc. (ISPC) Q2 2024 Earnings Call
August 6, 2024 · Replay with transcript and chapters
iSpecimen Inc. (ISPC) Q1 2024 Earnings Call
May 7, 2024 · Replay with transcript and chapters
iSpecimen Inc. (ISPC) Q4 2023 Earnings Call
March 14, 2024 · Replay with transcript and chapters
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call
November 2, 2023 · Replay with transcript and chapters
iSpecimen Inc. (ISPC) Q2 2023 Earnings Call
August 2, 2023 · Replay with transcript and chapters
iSpecimen Inc. (ISPC) Q1 2023 Earnings Call
May 4, 2023 · Replay with transcript and chapters
Research Ispecimen Inc.
Ispecimen Inc. investor report
Review AI stock analysis and investor report context for ISPC:NASDAQ.
Ispecimen Inc. company profile
View the public company page for Ispecimen Inc. on 6ix.
Ispecimen Inc. news
Read company news and market updates connected to Ispecimen Inc..
Ispecimen Inc. investor events
Find investor webinars, events, and replay context for Ispecimen Inc..